跳至主要内容
临床试验/IRCT201604094920N7
IRCT201604094920N7已完成3 期

Image contrast quality and safety comparison of OPAQUESOL (Shahid Ghazi) and OMNIPAQUE in CT-Scan with contrast

Shahid Ghazi Pharmaceutical Company0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 65 years(—)
性别
All

入选标准

  • Patients aged between 45 to 65 years old; Referred subjects for CT-Scan by contrast media; Provided signed and dated informed consent subjects.
  • Exclusion criteria: Patient with contrast administration in the past 7 days; Subjects have known contra-indication and allergy to contrast administration; Renal insufficiency as defined by GFR < 50; Lactation; Pregnancy; Bronchial asthma; Clinical unstable condition (hemodynamic, respiratory, neurologic); Emergency cases; Hyperthyroidism; End-stage patients.

排除标准

  • 未提供

研究者

发起方
Shahid Ghazi Pharmaceutical Company

相似试验